Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

Table 6 Intention-to-treat analysis for quality of life

Domains (mean ± SD)	SF-36* before	SF-36* after	P value
Physical function	69 ± 30	82 ± 23	0.00**
Role physical	61 ± 47	86 ± 32	0.02**
Body pain	70 ± 26	81 ± 19	0.00**
General health	55 ± 21	73 ± 18	0.00**
Vitality	62 ± 24	73 ± 22	0.02**
Social functioning	73 ± 29	81 ± 23	0.03**
Role emotional	68 ± 45	83 ± 38	0.17
Mental health	75 ± 20	83 ± 17	0.00**

ISSN: 1471-230X